Early intervention in Alzheimer’s disease: a health economic study of the effects of diagnostic timing
Open Access
- 7 May 2014
- journal article
- research article
- Published by Springer Nature in BMC Neurology
- Vol. 14 (1) , 101
Abstract
Intervention and treatment in Alzheimer’s disease dementia (AD-dementia) can be cost effective but the majority of patients are not diagnosed in a timely manner. Technology is now available that can enable the earlier detection of cognitive loss associated with incipient dementia, offering the potential for earlier intervention in the UK health care system. This study aimed to determine to what extent the timing of an intervention affects its cost-effectiveness.Keywords
This publication has 35 references indexed in Scilit:
- Mild cognitive impairment: Disparity of incidence and prevalence estimatesAlzheimer's & Dementia, 2012
- Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's & Dementia, 2011
- The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's & Dementia, 2011
- The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's & Dementia, 2011
- 2011 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2011
- Enrichment through biomarkers in clinical trials of Alzheimer's drugs in patients with mild cognitive impairmentNeurobiology of Aging, 2010
- Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectivesNature Reviews Drug Discovery, 2010
- Detecting Dementia: Novel Neuropsychological Markers of Preclinical Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 2003
- CSF markers for incipient Alzheimer's diseaseThe Lancet Neurology, 2003
- Mild Cognitive ImpairmentArchives of Neurology, 1999